9BK5 image
Entry Detail
PDB ID:
9BK5
Title:
Structure of LNG binder complex
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2024-04-26
Release Date:
2024-10-09
Method Details:
Experimental Method:
Resolution:
2.68 Å
R-Value Free:
0.26
R-Value Work:
0.23
R-Value Observed:
0.24
Space Group:
I 41 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:LNG binder
Chain IDs:A
Chain Length:121
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polypeptide(L)
Description:Alpha-cobratoxin
Chain IDs:B
Chain Length:71
Number of Molecules:1
Biological Source:Naja kaouthia
Ligand Molecules
Primary Citation

Abstact

Snakebite envenoming remains a devastating and neglected tropical disease, claiming over 100,000 lives annually and causing severe complications and long-lasting disabilities for many more1,2. Three-finger toxins (3FTx) are highly toxic components of elapid snake venoms that can cause diverse pathologies, including severe tissue damage3 and inhibition of nicotinic acetylcholine receptors, resulting in life-threatening neurotoxicity4. At present, the only available treatments for snakebites consist of polyclonal antibodies derived from the plasma of immunized animals, which have high cost and limited efficacy against 3FTxs5-7. Here we used deep learning methods to de novo design proteins to bind short-chain and long-chain α-neurotoxins and cytotoxins from the 3FTx family. With limited experimental screening, we obtained protein designs with remarkable thermal stability, high binding affinity and near-atomic-level agreement with the computational models. The designed proteins effectively neutralized all three 3FTx subfamilies in vitro and protected mice from a lethal neurotoxin challenge. Such potent, stable and readily manufacturable toxin-neutralizing proteins could provide the basis for safer, cost-effective and widely accessible next-generation antivenom therapeutics. Beyond snakebite, our results highlight how computational design could help democratize therapeutic discovery, particularly in resource-limited settings, by substantially reducing costs and resource requirements for the development of therapies for neglected tropical diseases.

Legend

Protein

Chemical

Disease

Primary Citation of related structures